SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-051565
Filing Date
2024-05-02
Accepted
2024-05-02 07:09:17
Documents
13
Period of Report
2024-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gern-20240502.htm   iXBRL 8-K 49628
2 EX-99.1 gern-ex99_1.htm EX-99.1 92510
3 GRAPHIC img50521483_0.jpg GRAPHIC 56707
  Complete submission text file 0000950170-24-051565.txt   348146

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT gern-20240502.xsd EX-101.SCH 27897
16 EXTRACTED XBRL INSTANCE DOCUMENT gern-20240502_htm.xml XML 4698
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 24905243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)